News About: Pharm. Industry
Small drugmakers plunging into deeper slump
Korea’s small and medium-sized posted sharp declines in their second-quarter operating profits, adding further anxiety to their already troubled financial health.
Analysts said sluggish demand for generic drugs an...
Pharmaceutical firms see their cash reserves shrinking
A growing number of pharmaceutical manufacturing firms in Korea are struggling to stabilize their cash flow in the midst of falling operating profits due to massive cut prices earlier this year, data show Wednesday.
...
Takeda completes Nycomed Korea acquisition
Takeda Korea has completed its acquisition of Nycomed with a company name “Takeda Korea Pharmaceutical Co.,” it was learned on Monday.
Takeda Korea said the incorporation would bring enhanced revenue, growth and di...
Dong-A to build 100 billion won biosimilar plant in Songdo
Korea’s large pharmaceutical company Dong-A Pharmaceutical reaffirmed its intention to advance into the biosimilar market, the company said in regulatory filing on Tuesday .
Biosimilars refer to subsequent versions...
LGIS, Ildong to jointly develop hepatitis B drug
LG Life Sciences (LGLS) said Tuesday that it signed with Ildong Pharmaceutical to jointly develop a new hepatitis B drug ‘Besiforvir.’
According to LGLS which has completed the late-stage Phase II trial through its...
Foreign products reliance makes Korean drug firms vulnerable
The government-mandated cuts in drug prices have prompted Korea’s leading drug maker to increase their dependence on foreign maker’s original drugs surge over the years.
Recent data from Yakup.com, a pharmaceutical...
Pharmaceutical firms pay 37 million won in annual salary on average
Most companies in the pharmaceutical sector are paying annual salaries near 37 million won to their new employees on average, statistics by on-line job portal Job Korea, Monday.
According to statistics, 572 enterpr...
Pharmaceutical salespeople in serious stress
The Ministry of Health and Welfare has launched a crackdown on unlawful drug marketing activities since August 2010. At that time, the ministry introduced a rule which slashes the price of a drug by up to 20 percent i...
Ferring’s inflammatory bowel disease drug approved
Ferring Pharmaceuticals Korea, the Korean subsidiary of European based Ferring BV, on Friday had its anti-inflammatory drug against Crohn’s disease approved.
The Korea Food and Drug Administration on Friday authori...
Drug makers betting on new combination products to tackle difficulties
Generic manufacturing has long been a major source of revenue for most Korean pharmaceutical firms. That heavy reliance and their weak overseas presence caused them to shirk from drug development as it costs huge amou...
